glp-1 drugs and gastroparesis Gastroparesis: What Patients Should Know? New data links GLP-1 agonists

Animals had free access to food and water

Introduction With high and rising rates of adiposity and related morbidity, mortality, and healthcare expenditures, recently approved glucagon-like peptide 1 receptor agonists and related combination obesity medications (collectively referred to as GLP-1s1) are shifting the treatment landscape shifting the treatment landscape (we collectively refer to these as GLP-1s given this common practical usage by clinicians, policymakers, and the public

What troubles me at the beginning of a medical career in a city with one of the largest concentrations of Medi-Cal patients in California is that the decision to deny GLP-1 medication coverage will result in a higher number of uncontrolled diabetes cases and a rise in cardiovascular events

2025;55:jjae160

Generally, it is recommended to administer Semaglutide GLP-1 once a week, on the same day each week, and it can be taken at any time, with or without food

Exendin-4 improved rat cortical neuron survival under oxygen/glucose deprivation through PKA pathway